The global pharmaceutical aseptic transfer market was valued at USD 1,058.55 million in 2023, and is projected to grow from USD 1,161.76 million in 2024 to USD 2,497.58 million by 2032, exhibiting a robust CAGR of 10.0% during the forecast period (2024–2032). The market's remarkable growth is fueled by rising regulatory scrutiny, increasing...

The global active pharmaceutical ingredient CDMO market size was valued at USD 193.7 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030. Increasing pharmaceutical R&D investments, patent expirations, and a rise in demand for generic drugs and biologic innovations propelling outsourcing are the factors driving the market....